What is the first-line antibiotic for acute bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic for Acute Bacterial Sinusitis

Amoxicillin with or without clavulanate is the first-line antibiotic for acute bacterial sinusitis, with the choice between them depending on risk factors for antibiotic resistance.

Treatment Algorithm

For Adults Without Risk Factors for Resistance

  • Standard-dose amoxicillin alone is appropriate for uncomplicated acute bacterial rhinosinusitis 1, 2
  • This recommendation is based on amoxicillin's effectiveness, safety, low cost, and narrow microbiologic spectrum 1

For Adults With Risk Factors for Resistance

Amoxicillin-clavulanate (high-dose: 2g twice daily) should be prescribed when any of the following are present 1, 2:

  • Antibiotic use within the past month 1
  • Moderate to severe symptoms or protracted illness 1
  • Age >65 years 1
  • Comorbid conditions (diabetes, chronic cardiac/hepatic/renal disease, immunocompromised) 1
  • Geographic regions with high rates (>10%) of penicillin-nonsusceptible Streptococcus pneumoniae 1
  • Close contact with daycare facilities 1
  • Recent hospitalization 1

For Children

Age ≥2 years, uncomplicated, mild-to-moderate:

  • Standard-dose amoxicillin (45 mg/kg/day in 2 divided doses) 1
  • In communities with high prevalence of nonsusceptible S. pneumoniae (>10%), use high-dose amoxicillin (80-90 mg/kg/day in 2 divided doses, max 2g/dose) 1

Age <2 years, attending daycare, recent antibiotics, or moderate-to-severe illness:

  • High-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses) 1, 3

Penicillin-Allergic Patients

For adults with penicillin allergy:

  • Doxycycline OR respiratory fluoroquinolone (levofloxacin or moxifloxacin) 1
  • For non-type I hypersensitivity: clindamycin plus third-generation oral cephalosporin (cefixime or cefpodoxime) 1

For children with penicillin allergy:

  • Cefdinir, cefuroxime, or cefpodoxime 1
  • Second- and third-generation cephalosporins carry almost no risk of serious allergic reaction in penicillin-allergic patients 1

Antibiotics NOT Recommended as First-Line

Macrolides (azithromycin, clarithromycin) and trimethoprim-sulfamethoxazole should NOT be used due to high resistance rates 1:

  • Macrolide-resistant S. pneumoniae >40% in the United States 1
  • Trimethoprim-sulfamethoxazole resistance: 50% for S. pneumoniae and 27% for H. influenzae 1

Duration of Therapy

  • Adults: 5-7 days of therapy is as effective as 10 days 1, 4
  • Children: 10-14 days or continue for 7 days after symptom resolution 1
  • Shorter courses (5 days) reduce adverse events without compromising efficacy 1

Special Considerations

For frontal, ethmoidal, or sphenoidal sinusitis:

  • Consider respiratory fluoroquinolones (levofloxacin, moxifloxacin) due to higher risk of complications 1

For vomiting children or those unable to take oral medications:

  • Single dose of ceftriaxone 50 mg/kg IV/IM, then switch to oral therapy after clinical improvement 1

Common Pitfalls to Avoid

  • Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days without worsening 1, 4
  • Watchful waiting for 3 days is appropriate even for patients with persistent symptoms, as many will improve without antibiotics 2, 4
  • Reassess at 72 hours if symptoms worsen or fail to improve, then consider changing or initiating antibiotics 1
  • Adverse events occur in 15-40% of patients on antibiotics, most commonly GI symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Executive Summary of the Clinical Practice Guideline on Adult Sinusitis Update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Research

Acute Rhinosinusitis: Rapid Evidence Review.

American family physician, 2025

Related Questions

What is the first‑line medication for acute bacterial sinusitis?
What is the appropriate treatment for a healthy 45-year-old man with acute bacterial sinusitis?
What is the recommended first-line treatment for acute bacterial sinusitis in a woman in her second trimester of pregnancy?
What is the recommended antibiotic regimen for acute bacterial rhinosinusitis, including first‑line therapy, alternatives for severe penicillin allergy, dosing, and duration?
What is the best antibiotic for acute bacterial sinusitis?
In a 6‑year‑old girl with itchy, dry, flaky scalp unresponsive to an over‑the‑counter shampoo containing olive oil, coconut oil and salicylic acid, what further treatment options are appropriate?
Is digoxin appropriate for managing heart failure in a patient with aortic stenosis?
What is the role of plasma exchange in the management of adult immune thrombocytopenia (ITP)?
What is the clinical significance of epidermal growth factor receptor (EGFR) mutations in advanced non‑squamous non‑small cell lung cancer?
How should an elderly patient with dementia who is engaging in coprophagia by eating her own and other residents' stool in a memory‑care unit of an assisted‑living facility be managed?
What is the appropriate diagnostic work‑up and analgesic management for acute severe lumbar pain in a 73‑year‑old man with diabetes, hyperglycemia, dyslipidemia, stage‑3 chronic kidney disease, elevated gamma‑glutamyl transferase, vitamin D deficiency, eosinophilia, foul‑smelling dark stools, abdominal distension, insomnia, anxiety and hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.